Migrén: vizsgálatok itt: Puerto Rico

In Puerto Rico 5 Also abroad 249

5 trials · From ClinicalTrials.gov, checked 2026. november 12.. Ask the study team whether a trial fits you.

3. fázisTaking people
A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
Where
San Juan
Életkor
12 év to 17 év
People
420 worldwide
Run by
AbbVie
See details and how to joinNCT06810505 · EU 2024-513836-28-00
3. fázisTaking people
A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine
Where
Bayamón, Caguas, Dorado, San Juan
Életkor
6 év to 17 év
People
450 worldwide
Run by
AbbVie
See details and how to joinNCT05711394 · EU 2022-501100-94-00
3. fázisTaking people
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
Where
Bayamón, Dorado, San Juan
Életkor
6 év to 17 év
People
1059 worldwide
Run by
AbbVie
See details and how to joinNCT05125302
3. fázisCsak meghívásos
Long-term Extension Study to Assess Adverse Events of Oral Atogepant Tablets in Pediatric Participants (6 to 17 Years of Age) With Migraine
Where
Bayamón, Caguas, Dorado, San Juan
Életkor
6 év to 17 év
People
650 worldwide
Run by
AbbVie
See details and how to joinNCT05707949 · EU 2022-501099-24-00
3. fázisCsak meghívásos
Long-term Extension Study to Assess Safety and Tolerability of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Pediatric Participants (Ages 6-17)
Where
Bayamón, Dorado, San Juan
Életkor
6 év to 17 év
People
1200 worldwide
Run by
AbbVie
See details and how to joinNCT05127954